Cirurgia de Estômago e Duodeno
Atualização de prática clínica da AGA sobre o manejo endoscópico de perfurações no trato gastrintestinal.
27 Out, 2021 | 12:34hEstudo randomizado | Gastrectomia distal laparoscópica vs. aberta para câncer gástrico localmente avançado.
26 Out, 2021 | 11:20hLaparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial – JAMA Surgery (gratuito por tempo limitado)
Comentário no Twitter
It is not clear whether laparoscopic (LDG) and open distal gastrectomy (ODG) produce similar long-term outcomes in advanced #gastriccancer. CLASS-01 trial firstly shows LDG results in similar 5-year OS compared to ODG in advanced gastric cancer https://t.co/uUBcLFeqsY
— JAMA Surgery (@JAMASurgery) October 20, 2021
Reconstrução em Y de Roux vs. Billroth-I após gastrectomia distal para câncer gástrico.
20 Set, 2021 | 13:39hIncidência e mortalidade globais do câncer gástrico, 1980-2018.
13 Ago, 2021 | 11:55hGlobal Incidence and Mortality of Gastric Cancer, 1980-2018 – JAMA Network Open
Ranitidina absolvida? Estudo do FDA mostra que a ranitidina não é convertida ao carcinógeno NDMA, independentemente da dieta.
12 Jul, 2021 | 11:23hEditorial: Ranitidine and Risk of N-Nitrosodimethylamine (NDMA) Formation
Comentário: Ranitidine: FDA finds no evidence of elevated NDMA, regardless of diet
Comentário no Twitter
Despite ranitidine (zantac) being pulled from market last year, a new study from the FDA did not find evidence that it increases concentrations of the carcinogenic metabolite people were worried about (i.e., it's probably safe). From @JAMA_current https://t.co/AdRic2GdXS
— Zack Williams (@QuantPsychiatry) June 28, 2021
In this crossover, randomized clinical trial, oral ranitidine did not significantly increase 24-hour urinary excretion of NDMA when administered with a noncured-meats diet or a cured-meats diet. https://t.co/EszRvfJOFJ
— JAMA (@JAMA_current) June 28, 2021